97 related articles for article (PubMed ID: 601065)
1. Immunological aspects of gliomas.
Ridley A
Proc R Soc Med; 1977 Dec; 70(12):867-9. PubMed ID: 601065
[No Abstract] [Full Text] [Related]
2. Immunobiology of human gliomas.
Bullard DE; Gillespie GY; Mahaley MS; Bigner DD
Semin Oncol; 1986 Mar; 13(1):94-109. PubMed ID: 2420011
[No Abstract] [Full Text] [Related]
3. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
4. Immunological aspects of intrinsic glial tumors.
Apuzzo ML; Mitchell MS
J Neurosurg; 1981 Jul; 55(1):1-18. PubMed ID: 7017079
[No Abstract] [Full Text] [Related]
5. Immunological studies in melanoma patients treated with BCG.
De Vries JE; Rümke P
Br J Cancer Suppl; 1973 Aug; 1():97-102. PubMed ID: 4804294
[TBL] [Abstract][Full Text] [Related]
6. Role of immunity in therapy of human cancer. Discussion.
Br J Cancer Suppl; 1973 Aug; 1():299-308. PubMed ID: 4804287
[No Abstract] [Full Text] [Related]
7. [Cancer and the lymphatic system].
Grekh IF
Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
[No Abstract] [Full Text] [Related]
8. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
9. Immunological reactions to gliomas.
Ridley A
Mod Trends Neurol; 1975; 6():249-66. PubMed ID: 1105142
[No Abstract] [Full Text] [Related]
10. Cytotoxicity of human peripheral lymphocytes for glioma, osteosarcoma, and glia cell lines.
Skurzak H; Steiner L; Klein E; Lamon E
Natl Cancer Inst Monogr; 1973 Jun; 37():93-102. PubMed ID: 4514736
[No Abstract] [Full Text] [Related]
11. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
12. Immunotherapy of gliomas: a review.
Ommaya AK
Adv Neurol; 1976; 15():337-59. PubMed ID: 779424
[No Abstract] [Full Text] [Related]
13. Immunological aspects of experimental brain tumors (review).
Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
[TBL] [Abstract][Full Text] [Related]
14. Role of activated macrophages in nonspecific resistance to neoplasia.
Hibbs JB
J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
[No Abstract] [Full Text] [Related]
15. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
Lee Y; Bigner DD
Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
[TBL] [Abstract][Full Text] [Related]
16. [Value of immunologic studies in malignant tumors of the human brain].
Romodanov AP; Lisianyĭ NI; Prikhodchenko IA
Zh Vopr Neirokhir Im N N Burdenko; 1983; (3):56-9. PubMed ID: 6310917
[No Abstract] [Full Text] [Related]
17. Immunotherapy of brain tumors--is there a future?
Mahaley MS
Clin Neurosurg; 1978; 25():382-7. PubMed ID: 710003
[No Abstract] [Full Text] [Related]
18. Immunotherapy of human leukemia.
Baker MA; Taub RN
Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
[No Abstract] [Full Text] [Related]
19. Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy.
Dufour FD; Morton DL
Surg Forum; 1977; 28():165-7. PubMed ID: 617405
[No Abstract] [Full Text] [Related]
20. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
